-
-
-
-
-
-
-
Royalty Pharma provides up to $500 million for TEVA vitiligo drug
-
-
-
-
-
-
-
Denali Therapeutics secures $275 million royalty deal with Royalty Pharma
-
-
-
-
-
-
-
Royalty Pharma prices $2 billion senior unsecured notes offering
-
-
-
-
-
-
-
Royalty Pharma adds two independent directors to board
-
-
-
-
-
-
-
Citi Reiterates Buy Rating on Royalty Pharma (RPRX)
-
-
-
-
-
-
-
Royalty Pharma plc (RPRX) to Acquire Royalty Interest in Geron’s (GERN) RYTELO for $125M
-
-
-
-
-
-
-
Buffett's Berkshire Hathaway Enters 8 New Stocks, Including Citi and Paramount Global; Adds to Apple and Chevron
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

